NAUT Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
234.0K
+23.2%
190.0K
0
0
0
Cost of Revenue
24.0K
+60.0%
15.0K
0
0
0
Gross Profit
210.0K
+20.0%
175.0K
0
0
0
Operating Expenses
16.9M
+6.3%
15.9M
-1.2%
16.1M
+4.5%
15.4M
-0.3%
15.5M
R&D
10.2M
+5.9%
9.6M
-1.0%
9.7M
+1.4%
9.6M
-0.3%
9.6M
SG&A
6.8M
+7.1%
6.3M
-1.4%
6.4M
+9.7%
5.8M
-0.3%
5.9M
Operating Income
-16737000
-6.2%
-15763000
+2.2%
-16124000
-4.5%
-15424000
+0.3%
-15472000
EBITDA
-16459000
-6.2%
-15491000
+1.9%
-15790000
-5.1%
-15019000
+0.2%
-15046000
Net Income
-15636000
-8.1%
-14469000
+1.6%
-14697000
-6.6%
-13781000
-1.5%
-13574000
EPS (Basic)
$-0.12
-9.1%
$-0.11
+8.3%
$-0.12
-9.1%
$-0.11
+0.0%
$-0.11
EPS (Diluted)
$-0.12
-9.1%
$-0.11
+8.3%
$-0.12
-9.1%
$-0.11
+0.0%
$-0.11
Shares (Diluted)
127.2M
+0.1%
127.1M
+0.4%
126.6M
+0.2%
126.4M
+0.1%
126.3M
Nautilus Biotechnolgy (NAUT) — Financials